ストックスクリーナーアプリを入手
1.985
0.25%
0.005
前日終値:
$1.98
開ける：
$1.98
24時間の取引高:
157.53K
Relative Volume:
0.24
時価総額：
$151.25M
収益：
$151.64M
当期純損益:
$-37.23M
株価収益率:
-3.6329
EPS:
-0.5464
ネットキャッシュフロー:
$-13.58M
1週間 パフォーマンス:
+5.31%
1か月 パフォーマンス:
-30.35%
6か月 パフォーマンス:
+32.33%
1年 パフォーマンス:
-31.08%
1日の値動き範囲:
$1.9645
$2.01
1週間の範囲:
$1.84
$2.02
52週間の値動き範囲:
$0.80
$3.44
Neuronetics Inc Stock (STIM) Company Profile
Compare STIM vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.985 | 151.25M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
99.05 | 171.40B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.54 | 119.65B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
297.24 | 114.01B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.47 | 64.45B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.09 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-09-11 | 開始されました | B. Riley Securities | Buy |
| 2026-07-20 | 開始されました | BTIG Research | Buy |
| 2024-08-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2018-07-24 | 開始されました | Canaccord Genuity | Buy |
すべてを表示
Neuronetics Inc (STIM) 最新ニュース
Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates - Zacks Investment Research
Neuronetics (NasdaqGM:STIM) Stock Forecast & Analyst Predictions - Simply Wall Street
STIM Looks 73.9% Overvalued on GF Value™ - GuruFocus
Neuronetics a new buy at B Riley on interventional psychiatry platform - Seeking Alpha
STIM Initiated Coverage On by B. Riley Securities -- Rating Set to Buy - GuruFocus
Neuronetics stock gains after B.Riley initiates coverage at Buy By Investing.com - Investing.com South Africa
Neuronetics stock gains after B.Riley initiates coverage at Buy - investing.com
B.Riley initiates Neuronetics stock coverage with buy rating - investing.com
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - Investing News Network
Neuronetics, Inc. Integrates TrakStar With AdvancedMD, Inc. To Deliver TMS Care Across Clinical, Operational, And Billing Workflows - marketscreener.com
A magnetic brain-treatment system links to patient records for the first time - Stock Titan
Neuronetics (STIM) Slips 2.46% to $2.77 as Key Support LoomsSystematic Flow - vinanet.vn
Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash - Stock Titan
Neuronetics (STIM) Results Breakdown: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: The Market Price Declines 1.59% in Latest TradingEarnings Miss Streak - vinanet.vn
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - The Globe and Mail
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - vinanet.vn
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - vinanet.vn
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics director Jorey Chernett buys $44,240 in company stock By Investing.com - Investing.com Canada
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Canada
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com UK
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Australia
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Inc (STIM) 財務データ
収益
当期純利益
現金流量
EPS
Neuronetics Inc (STIM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | Officer |
Aug 18 '26 |
Proposed Sale |
3.21 |
121,033 |
388,274 |
0 |
| Chernett Jorey | 10% Owner |
Aug 14 '26 |
Buy |
3.16 |
14,000 |
44,240 |
10,602,988 |
| Chernett Jorey | 10% Owner |
Jul 14 '26 |
Buy |
1.78 |
35,000 |
62,300 |
10,588,988 |
| Sullivan Keith J | Former Officer and Director |
Jun 08 '26 |
Proposed Sale |
1.29 |
42,164 |
54,345 |
0 |
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
5.59%
0.18%
大文字化:
|
ボリューム (24 時間):